Published in Invest Ophthalmol Vis Sci on November 01, 2005
Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res (2009) 1.85
TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene (2009) 1.52
Toll-like receptors and corneal innate immunity. Curr Mol Med (2006) 1.44
Staphylococcus aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and myeloid differentiation factor 88. Infect Immun (2006) 1.43
Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis. Infect Immun (2007) 1.27
Toll-like receptors at the ocular surface. Ocul Surf (2008) 1.18
IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2009) 1.11
Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis. J Infect Dis (2010) 1.07
Toll-like receptors in ocular surface disease. Exp Eye Res (2010) 1.05
Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis. PLoS Pathog (2010) 1.04
Toll-like receptors and the eye. Invest Ophthalmol Vis Sci (2006) 1.04
Expression of toll-like receptors in human limbal and conjunctival epithelial cells. Mol Vis (2007) 0.96
Animal models of bacterial keratitis. J Biomed Biotechnol (2011) 0.93
DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines. Mol Oral Microbiol (2010) 0.91
Polyethyleneimine (PEI) mediated siRNA gene silencing in the Schistosoma mansoni snail host, Biomphalaria glabrata. PLoS Negl Trop Dis (2011) 0.91
TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway. Invest Ophthalmol Vis Sci (2013) 0.90
TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation. Am J Pathol (2011) 0.90
Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea. J Immunol (2012) 0.90
The effects of whole mushrooms during inflammation. BMC Immunol (2009) 0.89
Extracellular matrix protein lumican promotes clearance and resolution of Pseudomonas aeruginosa keratitis in a mouse model. PLoS One (2013) 0.89
Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia. J Biomed Biotechnol (2011) 0.88
3D quantitative imaging of unprocessed live tissue reveals epithelial defense against bacterial adhesion and subsequent traversal requires MyD88. PLoS One (2011) 0.87
Antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotechnology (2007) 0.87
High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis. J Immunol (2015) 0.84
Screening toll-like receptor markers to predict latent tuberculosis infection and subsequent tuberculosis disease in a Chinese population. BMC Med Genet (2015) 0.82
Interferon regulatory factor-1 in flagellin-induced reprogramming: potential protective role of CXCL10 in cornea innate defense against Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci (2013) 0.80
The delayed response of Toll-like receptors may relate to Pseudomonas aeruginosa keratitis exacerbating rapidly at the early stages of infection. Eur J Clin Microbiol Infect Dis (2009) 0.80
Toll-Like Receptor 9 Signaling in Dendritic Cells Regulates Neutrophil Recruitment to Inflammatory Foci following Leishmania infantum Infection. Infect Immun (2015) 0.78
Nona-D-arginine amide suppresses corneal cytokines in Pseudomonas aeruginosa keratitis. Cornea (2010) 0.78
Unexpected Roles for Toll-Like Receptor 4 and TRIF in Intraocular Infection with Gram-Positive Bacteria. Infect Immun (2015) 0.77
Pattern recognition receptors in microbial keratitis. Eye (Lond) (2015) 0.76
Toll-like receptor-associated keratitis and strategies for its management. 3 Biotech (2015) 0.75
NLRC4 regulates caspase-1 and IL-1beta production in a CD11blowLy6Glow population of cells required for resistance to Pseudomonas aeruginosa keratitis. PLoS One (2017) 0.75
Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res (2002) 1.35
Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice. J Immunol (2003) 1.28
Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis. Infect Immun (2007) 1.27
Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation. J Immunol (2007) 1.27
TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2006) 1.20
Beta-defensin-2 promotes resistance against infection with P. aeruginosa. J Immunol (2009) 1.14
SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. J Immunol (2006) 1.13
IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2009) 1.11
Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J Immunol (2009) 1.08
Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sci (2005) 1.08
Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice. Curr Eye Res (2004) 1.06
TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses. Infect Immun (2011) 1.06
ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2007) 1.06
VIP and growth factors in the infected cornea. Invest Ophthalmol Vis Sci (2011) 1.04
Toll-like receptors and the eye. Invest Ophthalmol Vis Sci (2006) 1.04
Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection. Eur J Immunol (2005) 1.04
Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci (2006) 1.01
Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci (2007) 1.00
Role of the Fas pathway in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2009) 1.00
NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice. J Immunol (2007) 0.97
The role of Langerhans cells in Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci (2002) 0.96
Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci (2002) 0.96
Pseudomonas aeruginosa-induced inflammation in the rat extended-wear contact lens model. Eye Contact Lens (2006) 0.95
Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray. Invest Ophthalmol Vis Sci (2003) 0.95
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
Substance P delays apoptosis, enhancing keratitis after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci (2008) 0.91
Caspase-1 inhibitor reduces severity of pseudomonas aeruginosa keratitis in mice. Invest Ophthalmol Vis Sci (2004) 0.91
Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated. Invest Ophthalmol Vis Sci (2008) 0.91
Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res (2004) 0.90
Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea. J Immunol (2012) 0.90
TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway. Invest Ophthalmol Vis Sci (2013) 0.90
Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection. J Immunol (2013) 0.90
HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis. PLoS Pathog (2013) 0.87
IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-gamma production. J Immunol (2002) 0.85
Rat silicone hydrogel contact lens model: effects of high- versus low-Dk lens wear. Eye Contact Lens (2008) 0.84
VIP promotes resistance in the Pseudomonas aeruginosa-infected cornea by modulating adhesion molecule expression. Invest Ophthalmol Vis Sci (2010) 0.84
Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea. Cornea (2012) 0.83
Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis. Invest Ophthalmol Vis Sci (2012) 0.83
HGF signaling impacts severity of Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2014) 0.82
IFN-gamma: regulation of nitric oxide in the P. aeruginosa-infected cornea. Ocul Immunol Inflamm (2006) 0.82
Testican-1 promotes resistance against Pseudomonas aeruginosa-induced keratitis through regulation of MMP-2 expression and activation. Invest Ophthalmol Vis Sci (2011) 0.80
IL-10 function, regulation, and in bacterial keratitis. J Ocul Pharmacol Ther (2014) 0.79
Pseudomonas aeruginosa binds to extracellular matrix deposited by human corneal epithelial cells. Invest Ophthalmol Vis Sci (2002) 0.79
TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction. Exp Eye Res (2004) 0.79
Development of a new extended-wear contact lens model in the rat. CLAO J (2002) 0.79
The role of VIP in cornea. Invest Ophthalmol Vis Sci (2012) 0.77
Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic. Invest Ophthalmol Vis Sci (2015) 0.77